Blog

Synergy research published as part of DEBRA’s most comprehensive study of epidermolysis bullosa (EB) patients

This year we are proud to have worked alongside DEBRA UK, the national charity supporting individuals and families affected by Epidermolysis Bullosa (EB), to produce vital insights into the lives of EB patients and their caregivers. A multi-pronged qualitative and qualitative research approach amongst healthcare professionals and patients was utilised to understand in full the

Synergy research published as part of DEBRA’s most comprehensive study of epidermolysis bullosa (EB) patients Read More »

Synergy insights inform Breast Cancer Now report highlighting need for improved referral pathways for secondary breast cancer

Synergy is pleased to have worked with Breast Cancer Now to conduct two waves of research since 2022 amongst GPs and Practice nurses to understand how early diagnosis rates of secondary breast cancer can be improved by exploring barriers to referral in primary care. The first wave of research in 2022 was highly commended at

Synergy insights inform Breast Cancer Now report highlighting need for improved referral pathways for secondary breast cancer Read More »

Synergy insights into delayed referral of metastatic breast cancer for Breast Cancer Now highly commended at 2023 BOBI Awards

We are very pleased to announce that Synergy insights have been highly commended in the Best Patient Centric Approach category at the 2023 BHBIA Best of Business Intelligence Awards. Synergy team members Charlotte, Larissa and Patrick worked alongside Breast Cancer Now to provide vital insight into improving early diagnosis rates of secondary breast cancer by

Synergy insights into delayed referral of metastatic breast cancer for Breast Cancer Now highly commended at 2023 BOBI Awards Read More »

Synergy research published by The BIA examines public opinion of rare disease funding & concludes NICE processes require fresh evidence

We are delighted that research we conducted for The Bioindustry Association has recently been published as part of their report examining the social values of treating rare diseases, which looks into public opinion of how rare diseases should be funded. During their recent large-scale review of its methods and processes, NICE concluded that there was

Synergy research published by The BIA examines public opinion of rare disease funding & concludes NICE processes require fresh evidence Read More »